Amarillo Biosciences, Inc. (AMAR) Company Profile

Amarillo Biosciences, Inc. Company Snapshot

Amarillo Biosciences, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amarillo Biosciences with three other companies in this sector in the United States: RegeneRx Biopharmaceuticals, Inc. (2018 sales of $69,667.00 ), Adhera Therapeutics Inc ($76,186.00 ), and Sangui Biotech International, Incorporated ($77,152.00 ).

Sales Analysis.

Amarillo Biosciences, Inc.

Stock Data:

Recent Stock Performance:

Current Price (11/8/2019): .35
(Figures in U.S. Dollars)

1 Week	-15.7%	13 Weeks	-15.8%

4 Weeks	-20.6%	52 Weeks	-40.1%

Amarillo Biosciences, Inc. Key Data:

Ticker:	AMAR	Country:	United States

Exchanges:	OTC	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2018 Sales	77,724 (Year Ending Jan 2019).	Employees:	4

Currency:	U.S. Dollars	Market Cap:	14,216,480

Fiscal Yr Ends:	December	Shares Outstanding:	40,216,351

Share Type:	Common	Closely Held Shares:	13,065,825

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.